Literature DB >> 18984363

Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report.

James J Leyden1, James Q Del Rosso, Guy F Webster.   

Abstract

This article reviews the anti-inflammatory and nonantimicrobial effects of antibiotics in acne and other diseases and examines issues relating to the emergence of decreased bacterial sensitivity to antibiotics and how these issues relate to clinical practice. It includes an overview of the inflammatory activities of some antibiotic agents and their potential for use in various dermatologic and nondermatologic diseases. It demonstrates that P. acnes-resistant organisms may be associated with therapeutic failure in some patients with acne, and that the prudent use of antibiotics is necessary to ensure that we can continue to use these drugs to combat disease effectively. It concludes that there are treatment strategies that can effectively minimize the potential for development of resistant P. acnes organisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18984363     DOI: 10.1016/j.det.2008.07.008

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  11 in total

1.  Benzoyl Peroxide Microsphere Formulations: What is the Science Supporting Microsphere Vehicle Technology and Clinical Use?

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2009-09

2.  Oral antibiotics in acne vulgaris: therapeutic response over 5 years.

Authors:  J Adawiyah; G Priya; B Roshidah
Journal:  Malays Fam Physician       Date:  2010-12-31

Review 3.  SARECYCLINE AND THE NARROW-SPECTRUM TETRACYCLINE CONCEPT: Currently Available Data and Potential Clinical Relevance in Dermatology.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2020-10-01

4.  Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 1: Antibiotic Prescribing Patterns, Sources of Antibiotic Exposure, Antibiotic Consumption and Emergence of Antibiotic Resistance, Impact of Alterations in Antibiotic Prescribing, and Clinical Sequelae of Antibiotic Use.

Authors:  James Q Del Rosso; Guy F Webster; Ted Rosen; Diane Thiboutot; James J Leyden; Richard Gallo; Clay Walker; George Zhanel; Lawrence Eichenfield
Journal:  J Clin Aesthet Dermatol       Date:  2016-04-01

5.  High resolution imaging of acne lesion development and scarring in human facial skin using OCT-based microangiography.

Authors:  Utku Baran; Yuandong Li; Woo June Choi; Goknur Kalkan; Ruikang K Wang
Journal:  Lasers Surg Med       Date:  2015-03-05       Impact factor: 4.025

6.  In vitro antibacterial activity of NB-003 against Propionibacterium acnes.

Authors:  J Pannu; A McCarthy; A Martin; T Hamouda; S Ciotti; L Ma; J Sutcliffe; J R Baker
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

7.  In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes.

Authors:  James J Leyden; Norman Preston; Cris Osborn; Ronald W Gottschalk
Journal:  J Clin Aesthet Dermatol       Date:  2011-05

Review 8.  From the Test Tube to the Treatment Room: Fundamentals of Boron-containing Compounds and their Relevance to Dermatology.

Authors:  James Q Del Rosso; Jacob J Plattner
Journal:  J Clin Aesthet Dermatol       Date:  2014-02

9.  Interaction and efficacy of Keigai-rengyo-to extract and acupuncture in male patients with acne vulgaris: a study protocol for a randomized controlled pilot trial.

Authors:  Kyu Seok Kim; Yoon-Bum Kim
Journal:  Trials       Date:  2011-03-19       Impact factor: 2.279

Review 10.  Synchronizing Pharmacotherapy in Acne with Review of Clinical Care.

Authors:  Sarvajnamurthy Aradhya Sacchidanand; Koushik Lahiri; Kiran Godse; Narendra Gajanan Patwardhan; Anil Ganjoo; Rajendra Kharkar; Varsha Narayanan; Dhammraj Borade; Lyndon D'souza
Journal:  Indian J Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.